Skincare brands keep adding a light-therapy device to their range, and most of them underestimate what they have taken on. An LED mask is not a hero product with a battery attached. It is an electrical appliance that emits optical radiation onto a customer’s face, and that puts it under a body of rules with nothing to do with the Cosmetics Act.
The gap between those two worlds is where launches stall.
A device leaves the cosmetic framework entirely
Cosmetic compliance is built around ingredients, labelling, and safety assessment of a formulation. None of that applies to a plastic shell full of diodes.
What applies instead is electrical safety, electromagnetic compatibility, battery transport rules if the unit is cordless, and photobiological safety — the assessment of whether the emitted light is hazardous, covered internationally by IEC 62471. Every destination market wraps its own conformity marking around that set. A brand whose regulatory experience consists of ingredient annexes and safety assessors is starting from zero here.
The second break point is claims. Describing a device as supporting skin appearance keeps it in consumer-appliance territory. Describing it as treating acne, or as a therapy for a diagnosed condition, moves it toward medical device classification in most jurisdictions, which brings clinical evidence requirements and a registration pathway measured in quarters rather than weeks. The same logic that governs home-use light and laser devices applies here, and it is decided by the marketing copy as much as by the hardware.
What the wavelengths do, and what they don’t
Marketing for this category tends to blur the mechanism. It is worth being precise, because the precision is what protects the claim.
Red light, typically in the 630 nm region, is used for its effect on fibroblast activity and is the wavelength most often associated with firmness and fine lines. Blue light near 415 nm is used against the bacteria implicated in acne. Near-infrared penetrates further and is generally positioned around comfort and recovery.
Two things follow. First, dose matters more than the number of diodes — output irradiance and session length determine what actually reaches the skin, and a panel with more lights running weaker is not automatically better. Second, an LED mask is not a brightening product in the way a serum is. Light does not remove existing pigment. A device positioned as a whitening tool is making a claim the hardware does not support, and that is a harder position to defend than a claim about firmness or overall skin appearance.
Eye safety is the exposure that ends brands
Of every risk in this category, ocular exposure is the one that produces the worst outcomes and the fastest regulatory attention. The device sits directly over the face, sessions run for ten to twenty minutes, and consumers reuse it for months.
Photobiological safety assessment exists precisely to classify that risk, and the resulting classification drives what the instructions have to say. Whether the design shields the eye area, whether goggles ship in the box, and whether the manual instructs the user to keep eyes closed are decisions that belong to the assessment, not to the packaging designer.
Instructions for use are part of the product here, not an afterthought. A device that is safe when used as directed is only safe if the direction is legible, translated properly, and physically present in the box. Brands that treat the manual as a cost line — reducing it to a pictogram card — are removing the mitigation the safety file relies on.
Why the commercial model is different too
A device is a considered purchase at several times the price of a cream, with a return rate driven by fit and comfort rather than by results. Masks that pinch the nose bridge, run hot, or refuse to sit flat on a smaller face come back regardless of how well the light works.
Then there is the after-sales tail. Warranty terms, spare parts, replacement straps, battery service, and a repair or replacement path all have to exist before the first unit ships. Retailers ask about this early because they carry the customer relationship when something fails.
The category also generates a different kind of review. Consumers reviewing a serum describe how it feels. Consumers reviewing a device describe whether it broke, whether the app worked, and whether the brand answered the email. Brands moving from formulation into hardware for the first time are usually staffed for the first conversation and not the second — which is why device launches in home care succeed or fail on operations as much as on the technology.
Settle these before you sign
The questions that separate a smooth device launch from a stalled one are mostly commercial rather than technical:
- Who holds the certification. If conformity documentation sits with the manufacturer and is not transferable, switching suppliers means starting the testing over.
- Which markets the existing file covers. Test reports for one region rarely satisfy another without supplementary work; find out what is missing before you commit to a launch calendar.
- Measured output, not claimed output. Ask for irradiance and wavelength data on production units, not on an engineering sample.
- Firmware and app ownership. If the device connects to a phone, the app is a product you now maintain, with its own store review cycles and privacy obligations.
- Liability allocation. Establish in the contract who carries responsibility for a safety incident, and confirm the insurance actually reflects it.
Brands that treat these as procurement details discover them at customs. Brands that settle them during supplier selection get a device SKU that behaves like a product line rather than a recurring problem — and the conservative, well-documented positioning that comes out of that process tends to hold up far better once real customer reviews start arriving. The same has been true across the wider home-device category, where the brands that overpromised early are not the ones still on shelf.
“At-home beauty devices are one of the categories buyers ask us about most, because the value proposition has to be explained differently than a cream or a serum — it is a bigger purchase decision and consumers want reassurance before they buy. In our conversations with brands sourcing light-therapy devices, the positioning that works usually pairs the technology story with very concrete, conservative usage guidance. Overpromising results, or downplaying the need for proper eye protection, is exactly what erodes trust fastest in this category once real customer reviews start rolling in.” — Hyejin Cho, Digital Marketing Specialist, Marketing and Communication Team at SPSCOS